Avista Therapeutics, a biotechnology company focused on developing gene therapies for rare ophthalmic conditions, has announced a strategic partner...
The U.S. cell and gene therapy clinical trials market is projected to grow significantly, reaching an estimated value of $14.68 billion by 2034, up...
Researchers are advancing CRISPR gene editing trials by employing engineered bacterial nanosyringes for precise genome integrations. These nanosyri...
Researchers have developed PRIDICT2.0 and ePRIDICT, computational tools designed to improve the efficiency of prime editing, a precise genome editi...
Recent advancements in genome sequencing technologies have enabled a comprehensive genetic study of Yanbian cattle, a breed native to China. Resear...
Researchers have successfully completed the chromosome-level genome assembly of Clinopodium barosmum, a plant species collected from Lijiang City, ...
Researchers at the University of Zurich have developed an AI tool named 'Pythia' to improve the precision of gene editing using CRISPR technology. ...
Health-care providers in the U.S. are significantly reducing the use of tracking pixels on their websites due to fears of litigation and regulatory...
Researchers at Penn State have developed a novel method for controlling micro-sized robots using sound waves, inspired by the natural acoustic comm...
A research team has developed a stereospecific glycosylation method that accommodates a wide variety of monosaccharides, including hexopyranoses an...